A new content series, Illumina’s German MiSeq snag, ONT First-half results, Natera gets IVDR certification, NIH grant-making continues apace, and more.
More on Biomni and Claude Science…
A new content series, Illumina’s German MiSeq snag, ONT First-half results, Natera gets IVDR certification, NIH grant-making continues apace, and more.